Volume | 37 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO.B | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
279.91 | 279.91 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
2 | 37 | - | 267.85 - 427.11 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
12:41:26 | 36 | US$ 284.30 | USD |
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO.B Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 279.91 | 294.06 | 279.91 | 279.91 | 7 | 0.00 | 0.00% |
1 Month | 279.91 | 304.53 | 267.85 | 279.91 | 10 | 0.00 | 0.00% |
3 Months | 332.20 | 357.67 | 267.85 | 312.70 | 43 | -52.29 | -15.74% |
6 Months | 303.05 | 357.67 | 267.85 | 329.42 | 189 | -23.14 | -7.64% |
1 Year | 375.52 | 427.11 | 267.85 | 334.25 | 126 | -95.61 | -25.46% |
3 Years | 613.47 | 879.00 | 267.85 | 500.26 | 110 | -333.56 | -54.37% |
5 Years | 290.13 | 879.00 | 267.85 | 461.72 | 154 | -10.22 | -3.52% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |